In positive news for India, Bharat Biotech the maker of the indigenous Covid-19 vaccine Covaxin has announced on Thursday (August 5) that it has received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities.
The approval was given by the National Institute of Pharmacy and Nutrition, Hungary, certifying the GMP for the manufacture of Covaxin.
Bharat Biotech has said that its certificate of GMP is now listed on the EudraGMDP database, which is the main database of the European Community of manufacturing authorizations and certificates of good manufacturing practice, and has plans to submit documentation for Emergency Use Authorization (EUA) in several additional countries worldwide.
This approval is a major achievement for Bharat Biotech in innovating, manufacturing, and supplying vaccines at global quality standards and has the potential to be a leading pharmaceutical company in the ongoing fight against the Covid-19 pandemic.
In a statement released by the company, it states that This recognition complements its commitment of driving world-class innovation and being a frontrunner in the research and development of vaccines.
Click here to subscribe to The Commune on Telegram and get the best stories of the day delivered to you personally.